Immunohistochemical comparison of E-cadherin expression in oral lichen planus with and without dysplasia
Journal of Dental School,
Vol. 35 No. 1 (2017),
2 May 2017
,
Page 26-31
https://doi.org/10.22037/jds.v35i1.24627
Abstract
Objectives E-cadherin is a transmembrane glycoprotein, which is responsible for cell adhesion and its expression decreases in dysplastic lesions. This study aimed to assess the expression of this marker in oral lichen planus (OLP) with and without dysplasia to assess its potential for use as a predictor of malignant transformation.
Methods This descriptive, cross-sectional study was conducted on 44 OLP specimens using immunohistochemistry (IHC) by streptavidin- biotin technique. For this purpose, E-cadherin antibody was used and the intensity score (IS), proportional score (PS) and total score (TS) were calculated. Data were analyzed using SPSS version 21. The relationship between the intensity of expression of E-cadherin and dysplastic changes was assessed using the Mann Whitney U test. P < 0.05 was considered significant.
Results The TS of E-cadherin expression was 3 to 6 and 3 in the superficial and deep layers of 100% of specimens with dysplasia, respectively. The TS of E-cadherin expression was 3 to 6 in the superficial layer of 82.5% of specimens and 3 in deep layers of 81.2% of specimens without dysplasia. According to the Mann Whitney U test, the expression of E-cadherin in the superficial (P = 0.90) and deep (P = 0.35) layers was not significantly different between the two groups of OLP with and without dysplasia.
Conclusion No significant difference was found in the expression of E-cadherin in OLP specimens with and without dysplasia. It may be concluded that in contrast to other preneoplastic lesions, dysplastic changes of OLP do not follow other malignant transformation patterns in the oral mucosa.
- Cadherins
- Lichen planus
- Oral
- Immunohistochemistry
How to Cite
References
Zakrzewska JM. Oral lichen planus: a review. Br J Oral Maxillofac Surg. 2001;39:407.
Canto AM, Müller H, Freitas RR, Santos PS. Oral lichen planus (OLP): clinical and complementary diagnosis. An Bras Dermatol. 2010;85:669–675.
Scully C, el-Kom M. Lichen planus: review and update on pathogenesis. J Oral Pathol. 1985;14:431–458.
Ismail SB, Kumar SK, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci. 2007;49:89–106.
Edwards PC, Kelsch R. Oral lichen planus: clinical presentation and management. J Can Dent Assoc. 2002;68:494–499.
Eisen D. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:431–436.
Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol. 1991;25:593–619.
Shen ZY, Liu W, Zhu LK, Feng JQ, Tang GY, Zhou ZT. A retrospective clinicopathological study on oral lichen planus and malignant transformation: analysis of 518 cases. Med Oral Patol Oral Cir Bucal. 2012;17:e943–e47.
Feller L, Lemmer J. Oral leukoplakia as it relates to HPV infection: A review. Int J Dent. 2012:540561.
Neville BW, Damm DD, Allen CM, Chi AC. Oral and maxillofacial pathology. 4th ed., Elsevier Co. Canada, 2016;chaps16:731–732.
Von Zeidler SV, de Souza Botelho T, Mendonça EF, Batista AC. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study. BMC Cancer. 2014;14:972.
Xu Z, Shen Z, Shi L, Sun H, Liu W, Zhou Z. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus. Ann Diagn Pathol. 2013;17:408–411.
Sousa FA, Paradella TC, Carvalho YR, Rosa LE. Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia. J Oral Sci. 2009;51:117–121.
Sun L, Feng J, Ma L, Liu W, Zhou Z. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma. Ann Diagn Pathol. 2013;17:486–489.
Ebrahimi M, Boldrup L, Wahlin YB, Coates PJ, Nylander K. Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus. Oral Oncol. 2008;44:634–638.
Li TJ, Cui J. COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma. Asian Pac J Trop Med. 2013;6:640–643.
Brackenbury R, Rutishauser U, Edelman GM. Distinct calcium-independent and calcium-dependent adhesion systems of chicken embryo cells. Proc Natl Acad Sci U S A. 1981;78:387–391.
El-Bahrawy MA, Pignatelli M. E-cadherin and catenins: molecules with versatile roles in normal and neoplastic epithelial cell biology. Microsc Res Tech. 1998;43:224–232.
Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg. 2000;87:992–1005.
Zhong LP, Li J, Zhang CP, Zhu HG, Sun J, Zhang ZY. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Arch Oral Biol. 2007;52:740–747.
Silva BS, Castro CA, Von Zeidler SL, Sousa SC, Batista AC, Yamamoto-Silva FP. Altered β-catenin expression in oral mucosal dysplasia: a comparative study. J Appl Oral Sci. 2015;23:472–478.
DU Y, Li H. Expression of E-cadherin in oral lichen planus. Exp Ther Med. 2015;10:1544–1548.
Sagari S, Sanadhya S, Doddamani M, Rajput R. Molecular markers in oral lichen planus: a systematic review. J Oral Maxillofac Pathol. 2016;20:115–121.
Rosado P, Lequerica-Fernández P, Fernández S, Allonca E, Villallaín L, de Vicente JC. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables. Br J Oral Maxillofac Surg. 2013;51:149–156.
Neppelberg E, Loro LL, Oijordsbakken G, Johannessen AC. Altered CD40 and E-cadherin expression—putative role in oral lichen planus. J Oral Pathol Med. 2007;36:153–160.
Neppelberg E, Johannessen AC. DNA content, cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus. Eur Arch Otorhinolaryngol. 2007;264:1223–1230.
Kyrodimou M, Andreadis D, Drougou A, Amanatiadou EP, Angelis L, Barbatis C, et al. Desmoglein-3/γ-catenin and E-cadherin/β-catenin differential expression in oral leukoplakia and squamous cell carcinoma. Clin Oral Investig. 2014;18:199–210.
Santos-García A, Abad-Hernández MM, Fonseca-Sánchez E, Julián-González R, Galindo-Villardón P, Cruz-Hernández JJ, et al. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2006;11:E100–E105.
Ishida K, Ito S, Wada N, Deguchi H, Hata T, Hosoda M, et al. Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia. Mol Cancer. 2007;6:62.
Asokan GS, Jeelani S, Gnanasundaram N. Promoter hypermethylation profile of tumour suppressor genes in oral leukoplakia and oral squamous cell carcinoma. J Clin Diagn Res. 2014;8:ZC09–ZC12.
- Abstract Viewed: 259 times
- PDF Downloaded: 122 times